Biotechnology News

Asthma Combo Seems Less Influenced by Genes

HealthDay - Mon Nov 23, 1:38 AM ET

THURSDAY, Nov. 19 (HealthDay News) -- People's genetic makeup has been shown to affect how they respond to asthma medications, but a new study finds that many people respond well to a particular combination treatment regardless of their genes.

  • NU Board of Regent Jim McClurg of Lincoln, left, takes notes during public testimony Friday, Nov. 20, 2009, at the regent's monthly meeting in Lincoln, Neb., regarding the expansion or restriction of embryonic stem cell research as Regent Brad Bohn looks on. The University of Nebraska's governing board on Friday voted down a proposal to restrict the school's rules governing embryonic stem-cell research beyond what the federal government allows.  (AP Photo/Bill Wolf)
    Measure to change U. of Neb. stem-cell rule fails AP - Fri Nov 20, 6:07 PM ET

    LINCOLN, Neb. - The University of Nebraska's governing board on Friday voted not to place tighter restrictions on embryonic stem cell research than those outlined under federal guidelines, which were expanded after President Barack Obama took office.

  • Stem cell cultures are held up at a lab. Embryonic stem cell therapy got a step closer to the clinic Thursday after US researchers said they filed a request for government approval of human trials.(AFP/Getty Images/File)
    Embryonic stem cell therapy closer to human trials AFP - Thu Nov 19, 1:13 PM ET

    CHICAGO (AFP) - Embryonic stem cell therapy got a step closer to the clinic Thursday after US researchers said they filed a request for government approval of human trials.

  • Company seeks to test stem cells for blindness Reuters - Thu Nov 19, 10:25 AM ET

    WASHINGTON (Reuters) - Advanced Cell Technology, a small Massachusetts-based biotechnology company, said on Thursday it has asked for approval to test human embryonic stem cells in treating a rare cause of blindness.

  • FDA to review Actelion's Zavesca for additional use Reuters - Thu Nov 19, 2:59 AM ET

    ZURICH (Reuters) - Actelion Ltd, Europe's largest biotech company, said on Thursday the U.S. Food and Drug Administration (FDA) would review use of its drug Zavesca to treat a rare neurodegenerative disease early next year.

  • Gene protects brain-eaters from mad cow-type disease Reuters - Wed Nov 18, 6:21 PM ET

    WASHINGTON (Reuters) - Villagers in the highlands of Papua New Guinea who ritualistically ate human brains but did not die of a brain disease called kuru have a genetic mutation that protects them, researchers said Wednesday.

  • Biotech Soybeans Good Source of Omega-3 HealthDay - Tue Nov 17, 11:49 PM ET

    TUESDAY, Nov. 17 (HealthDay News) -- Oil from genetically modified soybeans boosts levels of an important omega-3 fatty acid in the body, which may reduce the risk of heart attacks, U.S. researchers say.

  • Stem Cells May Improve Heart Bypass Results HealthDay - Tue Nov 17, 11:48 PM ET

    TUESDAY, Nov. 17 (HealthDay News) -- Patients who received bone marrow stem cell transplants during coronary bypass surgery (CABG) experienced "excellent long-term safety and survival," say German researchers, who also noted the first promising results for stem cell transplantation during mitral valve repair.

  • Icelandic gene pioneer Decode files for bankruptcy Reuters - Tue Nov 17, 3:01 PM ET

    WASHINGTON (Reuters) - Iceland's Decode Genetics Inc, a pioneer in genetic research, has filed for bankruptcy protection, weighed down by debts after 13 years of failing to make a profit.

  • A Taiwanese group has entered the running for the 10-million-dollar Archon X Prize for Genomics competition, the biggest medical prize in history, organizers said Tuesday. Cracker will take part in the international competition that aims to unearth new ways of rapid, cost-effective whole human genome sequencing.(Archon X Prize for Genomics)
    Taiwan firm enters $10 million genome contest AFP - Tue Nov 17, 2:19 PM ET

    LOS ANGELES (AFP) - A Taiwanese group has entered the running for the 10-million-dollar Archon X Prize for Genomics competition, the biggest medical prize in history, organizers said Tuesday.

  • Genome advances promise personalized medical treatment McClatchy Newspapers - Mon Nov 16, 3:48 PM ET

    WASHINGTON — A whirlwind of activity is under way to apply the findings of the $3 billion Human Genome Project to improve health care in the United States and around the world.

  • Lawmakers used Genentech statements: report Reuters - Sun Nov 15, 2:15 PM ET

    NEW YORK (Reuters) - Lobbyists working for biotech company Genentech wrote statements for more than a dozen lawmakers in the official record of the House debate on the health care bill, The New York Times reported on Sunday, citing e-mails.

  • Mutant genes linked to Parkinson's in some: study Reuters - Sun Nov 15, 1:20 PM ET

    HONG KONG (Reuters) - People of Japanese and European descent who have mutant versions of five genes may be at higher risk of developing Parkinson's disease, two large teams of researchers have found.

  • FILE - In this May 28, 2008 file photo, Genzyme's Manufacturing Facility is seen, in the Allston neighborhood of Boston. Federal health regulators said Friday, Nov. 13, 2009, they have found tiny particles of trash in drugs made by biotechnology firm Genzyme. (AP Photo/Bizuayehu Tesfaye, file)
    FDA finds bits of steel, rubber in Genzyme drugs AP - Fri Nov 13, 5:54 PM ET

    WASHINGTON - Federal health regulators have found tiny particles of trash in drugs made by Genzyme, the second time this year the biotechnology company has been cited for contamination issues.

  • K.C., the first animal produced by cloning from a cell taken from a carcass, in an undated photo courtesy of the genomics services company Viagen. REUTERS/Candace Dobson/Viagen/Handout
    Welcome to the Clone Farm Reuters - Fri Nov 13, 7:38 AM ET

    ENID, Oklahoma (Reuters) - To the untrained eye, Pollard Farms looks much like any other cattle ranch. Similar looking cows are huddled in similar looking pens. But some of the cattle here don't just resemble each other. They are literally identical -- clear down to their genes.

  • Gene Therapy Brings New Muscle to Monkeys HealthDay - Thu Nov 12, 11:49 PM ET

    THURSDAY, Nov. 12 (HealthDay News) -- Researchers are reporting that injections of genes into the leg muscles of monkeys helped the animals gain muscle size and strength without side effects.

  • Gene therapy strengthens muscles in monkeys Reuters - Wed Nov 11, 2:42 PM ET

    WASHINGTON (Reuters) - A gene therapy treatment that stops the breakdown of muscle appeared safe in monkeys and may build up muscle, too, researchers reported on Wednesday.

  • Pedro the Chimpanzee sits in his enclosure in Berlin Zoo, June 9, 2009. REUTERS/Fabrizio Bensch
    Why can't chimps talk? It's more than just genes Reuters - Wed Nov 11, 2:12 PM ET

    WASHINGTON (Reuters) - Why can humans talk and chimps cannot? Researchers said on Wednesday they have another clue and it lies not simply in the genetic code, but in how the genes function.

  • Scientists want debate on animals with human genes Reuters - Mon Nov 9, 7:06 PM ET

    LONDON (Reuters) - A mouse that can speak? A monkey with Down's Syndrome? Dogs with human hands or feet? British scientists want to know if such experiments are acceptable, or if they go too far in the name of medical research.

  • Gene Therapy for Fatal Brain Disorder 'Just the Beginning' HealthDay - Thu Nov 5, 11:48 PM ET

    THURSDAY, Nov. 5 (HealthDay News) -- The reported success of gene therapy in treating two children with adrenoleukodystrophy (ALD) brings hope to patients with the potentially crippling and fatal brain disorder and their families, says a nonprofit group that supports ALD research.

  • Genes Linked to 'Pot' Belly HealthDay - Thu Nov 5, 11:48 PM ET

    THURSDAY, Nov. 5 (HealthDay News) -- New research sheds light on the possible link between the genes you inherit and the size of your belly.

  • Company sequences whole human genome for $1,700 Reuters - Thu Nov 5, 7:24 PM ET

    WASHINGTON (Reuters) - Want to know your entire DNA sequence? A California company has done it for as little as $1,700.

  • Stem cell cultures are held up at a lab. A breakthrough mix of stem cell and gene therapy halted a lethal brain-wasting illness in two young boys, and could prove effective against other genetic disorders, researchers reported Thursday.(AFP/Getty Images/File)
    Gene therapy beats back brain wasting disease: study AFP - Thu Nov 5, 6:09 PM ET

    PARIS (AFP) - A breakthrough mix of stem cell and gene therapy halted a lethal brain-wasting illness in two young boys, and could prove effective against other genetic disorders, researchers reported Thursday.

  • New gene therapy halts 2 boys' rare brain disease AP - Thu Nov 5, 5:12 PM ET

    WASHINGTON - French scientists mixed gene therapy and bone marrow transplants in two boys to seemingly halt a brain disease that can kill by adolescence. The surprise ingredient: They disabled the HIV virus so it couldn't cause AIDS, and then used it to carry in the healthy new gene.

  • Scientists halt brain disease with new gene therapy Reuters - Thu Nov 5, 3:36 PM ET

    LONDON (Reuters) - Scientists have managed to halt a rare and fatal brain disease with an experimental gene therapy technique using a deactivated version of the AIDS virus, a study published on Thursday showed.

  • Genes may be important in back, neck pain Reuters - Wed Nov 4, 12:31 PM ET

    NEW YORK (Reuters Health) - A person's genetic makeup may play an important role in the odds of suffering neck or back pain, new research suggests.

  • Human Genome 2nd lupus trial succeeds Reuters - Mon Nov 2, 1:24 PM ET

    BOSTON/LONDON (Reuters) - Human Genome Sciences Inc said its experimental lupus drug Benlysta eased symptoms in more than 43 percent of patients who took it in a clinical trial, paving the way for approval of the first new treatment for the disease in 50 years.

  • Amgen, Amerisource sued over drug kickback scheme Reuters - Fri Oct 30, 4:19 PM ET

    NEW YORK (Reuters) - Biotechnology giant Amgen Inc and drug wholesaler AmerisourceBergen Corp were sued on Friday by 14 U.S. states and the District of Columbia over an alleged kickback scheme designed to boost sales of Amgen's popular anemia drug, Aranesp.

  • Genes may explain why churchgoers are teetotalers Reuters - Fri Oct 30, 4:02 PM ET

    NEW YORK (Reuters Health) - Churchgoers have been found to have lower rates of drinking and smoking than those who spend their Sundays elsewhere. Now a new study suggests that for adults, it may not be church attendance itself that explains much of the phenomenon. It might be genes.

  • A Mexican farmer takes part in a protest in Mexico City in January 2009. As scientists race the clock to increase food production worldwide, new trials to plant genetically-modified maize have stoked anger in Mexico, the cradle of corn.(AFP/File/Ronaldo Schemidt)
    Tests on treasured maize ignite fears in Mexico AFP - Thu Oct 29, 11:30 AM ET

    MEXICO CITY (AFP) - As scientists race the clock to increase food production worldwide, new trials to plant genetically-modified maize have stoked anger in Mexico, the cradle of corn.

1  2    Next